Unranked

Corbus Pharmaceuticals Holdings, Inc.

CRBP

$7.60

-5.12% (24h)

Last updated: 1 second ago

Market Cap

$140.81M

Volume (24h)

194.55K

Last Close (7D)

$7.60

View on TradingView

Price Chart

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

Website

www.corbuspharma.com

Country

🇺🇸 United States

A clinical-stage biotech developing drugs that target the endocannabinoid system to treat serious inflammatory and fibrotic diseases including systemic sclerosis, lupus, and NASH.

🔬 Pipeline centered on lenabasum, an endocannabinoid-mimicking molecule for rare inflammatory diseases

Key Stats

52-Week Range

$6.72$20.56

Beta2.59

Trailing P/EN/A

Forward P/E-1.50

Trailing EPS-5.74

Avg Volume402.08K

Enterprise Value$11.39M

Shares Outstanding18.53M

Earnings & Analyst

Next Earnings2026-08-11

EPS Estimate-1.24

Target Mean Price$36.50

RecommendationStrong Buy

Recommendation Mean1.11

Latest News

SeekingAlpha · Jun 1, 2026
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Key Insights from HNSCC KOL Event Transcript
SeekingAlpha · May 27, 2026
Corbus Pharmaceuticals: I'd Preach Caution After Selloff On Latest Data Drop
Benzinga · May 27, 2026
Wedbush Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $30
ChartMill · May 26, 2026
Tuesday's session: top gainers and losers
ChartMill · May 26, 2026
Top stock movements in today's session.
ChartMill · May 26, 2026
Gapping stocks in Tuesday's session